Client First Capital’s Johnson & Johnson JNJ Stock Holding History

Client First Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	+815	New	+$190K	0.08%	28

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Client First Capital's JNJ Position: Q2 2026 in Review

Client First Capital opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 815 shares worth $207K. The stake represents 0.08% of the portfolio and ranks #28 among its holdings.

2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Client First Capital held 815 shares of Johnson & Johnson worth $207K as of Q2 2026.
Johnson & Johnson was a new Client First Capital position in Q2 2026.
Johnson & Johnson made up 0.08% of Client First Capital's portfolio in Q2 2026, its #28 holding.
2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Client First Capital's 13F filing for Q2 2026, filed 13 Jul 2026.